Infectious diseases don't wait.
Neither do we

We protect children's futures from pregnancy through
adolescence with equitable science

Get to know us


Penta is an international independent scientific network dedicated to child health. Our work is the result of a passionate collaboration between healthcare professionals and researchers in 124 clinical sites and 26 cohorts across 27 countries around the world.

Through our studies and partnerships, we develop and deliver world-class research and training in paediatric infectious diseases to improve the lives of women and children, wherever they live.

Are you interested joining the Penta ID Network? Complete this form to apply.

Meet the 2026 Penta Brighter Future Award (BFA) winners!

This prestigious biennial award recognises visionary leaders dedicated to dismantling health inequities in maternal and child infectious diseases, specifically targeting HIV, tuberculosis (TB), vaccine access and the fortification of fragile health systems.

Penta Strategy 2025-2029: building on progress, driving strategic impact

Building on the results of our previous strategy, Penta’s 2025-2029 Strategic Plan focuses on accelerating scientific impact through high-quality research and strategic partnerships, especially in regions with the greatest need.

Penta advocates for equitable access to healthcare across all activities and strives to engage with affected and at-risk communities to maximise impact.

 

Current Penta studies around the World



Always expanding

Penta continues to grow, bringing together healthcare professionals, researchers and scientists worldwide to address a wide range of healthcare issues.
0

Members

0

Countries

0

Years of activity

0

Ongoing studies and projects

Previous

Latest News

Next

Penta announces 2026 Brighter Future Award winners, honouring global champions of infectious disease equity

20 Feb, 2026

Padova, Italy – February 20, 2026 – In observance of the World Day of Social Justice, Penta Foundation ETS is proud to announce the recipients of the 
Read More

Right-sizing antibiotic treatment, highlights from the PediSEP-1 kick-off meeting 

29 Jan, 2026

From January 19–20, 2026, the PediSEP-1 consortium gathered in Mombasa, Kenya, for the official launch the project, designed to move paediatric care away from a “one-size-fits-all” approach and toward a…
Read More

Penta Young Reporters win “Highly recommended” at PMEA awards

26 Jan, 2026

We are delighted that our Penta Young Reporters project was nominated and received a “Highly Recommended” recognition in the Excellence in Engaging and Educating Patients category at the 
Read More

PIPELINE‑RSV International trial achieves first UK green light: St George’s Hospital is activated as the first study site

20 Jan, 2026

The PIPELINE‑RSV International Trial has reached an important milestone with the first official green light for site activation at St George’s University Hospitals NHS Foundation Trust in London,
Read More

NeoSep1 Part 1 study shows promising antibiotic options for newborns with suspected sepsis

09 Jan, 2026

A paper published in the journal Antimicrobial Agents and Chemotherapy (AAC) reports that off-patent antibiotics, fosfomycin and flomoxef, when used at standard doses,
Read More

Keep up to date with the latest Penta news

Sign up to receive our monthly Penta Newsletter filled with the latest news on our studies, projects and people